Press/กด CtrlหรือCmd + P to print
or save as PDF

Cyclodextrin-Based Formulations: A Non-Invasive Platform for Targeted Drug Delivery (SCOPUS)

Last modified: July 6, 2023
You are here:
Estimated reading time: 1 min
Research Article: Cyclodextrin-Based Formulations: A Non-Invasive Platform for Targeted Drug Delivery
Author: Chutimon Muankaew and Thorsteinn Loftsson
Email: chutimon.mua@siam.edu
Department|Faculty: Faculty of Pharmacy, Siam University, Bangkok 10160
Published Basic and Clinical Pharmacology and Toxicology (BCPT), Volume 122, Issue 1 January 2018 Pages 46-55

Citation

Muankaew C., & Loftsson T. (2018). Cyclodextrin-based formulations: A non-invasive platform for targeted drug delivery. Basic and Clinical Pharmacology and Toxicology (BCPT), 122(1), 46.55.


ABSTRACT

Cyclodextrins (CDs) are recognized as promising pharmaceutical excipients due to their unique ability to form watersoluble inclusion complexes with various poorly soluble compounds. The numerous investigations on CDs and their use in nanomedicine have received considerable attention in the last three decades, leading to the rapid development of new CD-containing formulations that significantly facilitate targeted drug delivery and controlled drug release, with consequent improvements in drug bioavailability. This MiniReview highlights the efficacy and recent uses of CDs for non-invasive drug delivery. Using ophthalmic and nasal drug delivery as examples, an overview of chemical properties, mechanisms of CDs on drug solubilization, stabilization and permeation, along with their toxicological profiles relevant to nasal and ocular administration, are provided and discussed. The recent development and application of CD-based nanocarrier systems for targeted drug delivery are summarized.


Cyclodextrin-Based Formulations: A Non-Invasive Platform for Targeted Drug Delivery

Faculty of Pharmacy, Siam University, Bangkok, Thailand